Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 5Mesothelioma, Malignant 4Lung Neoplasms 4Laryngeal Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Mouth Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Medulloblastoma 2Lymphoid Interstitial Pneumonia 2Gallbladder Neoplasms 2Carcinoma 2Vaginal Neoplasms 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sinonasal undifferentiated carcinoma 1Prostatic Neoplasms 1Penile Neoplasms 1PRETEXT I Hepatoblastoma 1Lymphatic Metastasis 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × PRETEXT I Hepatoblastoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡